Payer formulary exclusions of apixaban: how patients respond and potential implications

S Deitelzweig, E Terasawa, A Kang… - Current Medical …, 2022 - Taylor & Francis
In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …
被引用次数：5 相关文章

Payer formulary exclusions of apixaban: how patients respond and potential implications

S Deitelzweig, E Terasawa, A Kang… - Current medical …, 2022 - pubmed.ncbi.nlm.nih.gov
In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …

Payer Formulary exclusions of apixaban: how patients respond and potential implications.

S Deitelzweig, E Terasawa, A Kang… - Current Medical …, 2022 - europepmc.org
In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …

[引用][C] Payer formulary exclusions of apixaban: how patients respond and potential implications

S Deitelzweig, E Terasawa, A Kang… - Current Medical …, 2022 - espace.library.uq.edu.au
In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …

Payer formulary exclusions of apixaban: how patients respond and potential implications

S Deitelzweig, E Terasawa, A Kang… - … Medical Research & …, 2022 - ingentaconnect.com
In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …